Investigating how specific mutations affect heart function in hypertrophic cardiomyopathy.
Mutation-Specific Calmodulin Kinase II Activation in Hypertrophic Cardiomyopathy
This study is looking at how certain genetic changes in heart proteins affect a key enzyme that helps your heart work properly, with the goal of finding better treatments for people with hypertrophic cardiomyopathy (HCM).
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Arizona NIH-funded |
| Lab location | 1 site (Tucson, United States) |
| Project ID | NIH-11064966 on NIH RePORTER |
What this research studies
This research focuses on hypertrophic cardiomyopathy (HCM), a genetic heart condition that affects many individuals worldwide. It aims to understand how specific mutations in heart proteins influence the activation of a key enzyme, CaMKIIδ, which plays a role in heart muscle contraction and overall heart function. By studying these mutations, the research seeks to uncover mechanisms that could lead to targeted therapies for patients with HCM. Patients may benefit from insights into their specific genetic mutations and how these affect their condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults diagnosed with hypertrophic cardiomyopathy, particularly those with known genetic mutations.
Not a fit: Patients without hypertrophic cardiomyopathy or those whose condition is not linked to specific genetic mutations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized treatment options for patients with hypertrophic cardiomyopathy based on their specific genetic mutations.
How similar studies have performed: Previous research has shown promising results in understanding the role of specific mutations in cardiac diseases, suggesting that this approach could yield valuable insights.
Where this research is happening
Tucson, United States
- University of Arizona — Tucson, United States (Active)
Researchers
- Principal investigator: Hauck, Garrett Turner — University of Arizona
- Study coordinator: Hauck, Garrett Turner
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.